Quince Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell QNCX and other ETFs, options, and stocks.

About QNCX

Quince Therapeutics, Inc. is a biopharmaceutical company, which engages in unlocking the power of a patient’s biology for the treatment of rare diseases. Its product includes eDSP, developed using their proprietary Autologous Intracellular Drug Encapsulation (AIDE) technology platform, which is a novel device combination that uses an automated process designed to encapsulate a drug into the patient’s own red blood cells. 

CEO
Dirk Thye
CEODirk Thye
Employees
38
Employees38
Headquarters
South San Francisco, California
HeadquartersSouth San Francisco, California
Founded
2012
Founded2012
Employees
38
Employees38

QNCX Key Statistics

Market cap
15.00M
Market cap15.00M
Price-Earnings ratio
-0.10
Price-Earnings ratio-0.10
Dividend yield
Dividend yield
Average volume
465.86K
Average volume465.86K
High today
$0.9299
High today$0.9299
Low today
$0.89
Low today$0.89
Open price
$0.90
Open price$0.90
Volume
21.09K
Volume21.09K
52 Week high
$45.50
52 Week high$45.50
52 Week low
$0.79
52 Week low$0.79

Stock Snapshot

With a market cap of 15M, Quince Therapeutics(QNCX) trades at $0.92. The stock has a price-to-earnings ratio of -0.10.

As of 2026-06-18, Quince Therapeutics(QNCX) stock has fluctuated between $0.89 and $0.93. The current price stands at $0.92, placing the stock +3.0% above today's low and -1.4% off the high.

The Quince Therapeutics(QNCX)'s current trading volume is 21.09K, compared to an average daily volume of 465.86K.

During the past year, Quince Therapeutics(QNCX) stock moved between $0.79 at its lowest and $45.50 at its peak.

During the past year, Quince Therapeutics(QNCX) stock moved between $0.79 at its lowest and $45.50 at its peak.

QNCX News

TipRanks 7d
Quince Therapeutics Stockholders Approve Reverse Split Authorization

Quince Therapeutics ( (QNCX) ) has provided an update. On June 11, 2026, Quince Therapeutics held its annual meeting of stockholders via live webcast, with app...

People also own

Based on the portfolios of people who own QNCX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.